Pasadena, CA, United States of America

Matthew Porteus


 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Dallas, TX (US) (2016)
  • Pasadena, CA (US) (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew Porteus

Introduction

Matthew Porteus is a prominent inventor based in Pasadena, California. He has made significant contributions to the field of gene targeting, a technique that allows for precise genetic modifications within the genome of a cell. With two patents to his name, Porteus is recognized for his innovative approaches to genetic engineering.

Latest Patents

Porteus's latest patents focus on the use of chimeric nucleases to stimulate gene targeting. This technique is essential for introducing genetic changes by modifying, repairing, attenuating, or inactivating specific genes or chromosomal DNA. His work emphasizes methods and compositions that achieve high efficiency in gene targeting within cells. Additionally, these patents relate to methods for treating or preventing genetic diseases in individuals who require such interventions. The disclosure also includes chimeric nucleases and vectors that encode these nucleases.

Career Highlights

Matthew Porteus is affiliated with the California Institute of Technology, where he continues to advance research in genetic engineering. His work has garnered attention for its potential applications in medicine and biotechnology. Porteus's innovative techniques are paving the way for new treatments for genetic disorders.

Collaborations

Porteus collaborates with notable scientists in his field, including David Baltimore, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Matthew Porteus is a leading figure in the realm of genetic engineering, with a focus on gene targeting and innovative methodologies. His contributions are shaping the future of genetic research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…